EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic diversity of human-associated Mycobacterium bovis in Canada

Meenu K Sharma iD, Olga Andrievskaia iD, Gregory J Tyrrell, Pierre-Marie Akochy, Inna Sekirov, Melissa Richard-Greenblatt iD, Angela Ma, Heather Adam, Mohey Alawa, Elizabeth Simms iD, Md Rashedul Islam iD, Melissa Rabb und 1 weitere

Microbiology Spectrum · 03.11.2026 · 14 (11)

DOI: 10.1128/spectrum.01485-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 03.11.2026. Verfasst von Meenu K Sharma und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Reference Centre for Mycobacteriology, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada. Hauptthemen laut MEDLINE: Mycobacterium bovis, Tuberculosis, Genetic Variation. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Food Inspection Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human infections caused by Mycobacterium bovis in Canada are not well documented. The following study analyzed M. bovis (excluding BCG) isolates identified in public health laboratories across Canadian provinces between 2000 and 2025. Whole-genome sequencing was used to catalog mutations linked to antimicrobial resistance and evaluate the genomic relatedness of isolates. The majority of samples in this study were non-respiratory (60%). Of 74 study isolates, 69 (93%) were phenotypically sensitive to first-line drugs isoniazid, rifampin, and ethambutol. The most frequently encountered M. bovis clusters belonged to M. tuberculosis complex lineages La 1.7 and La 1.8. Although some isolates showed phylogenetic clustering, their lack of spatial and temporal relatedness suggested sporadic cases rather than local M. bovis transmission. Of all first-line drugs evaluated, isoniazid showed the lowest concordance (94.4%) between phenotypic and genotypic methods. The isolates in this study harbor some mutations that are not currently documented in the WHO mutation catalog, indicating that these variants may be rare. The findings suggest that the prevalence of M. bovis infection in Canada is low with cases unlikely to be acquired through human-to-human transmission. IMPORTANCE Incidence of human infections due to Mycobacterium bovis in Canada is largely unknown as these data are not collected or annually published. This research is a first effort to identify historical M. bovis isolates that were available for culture, had drug susceptibility testing data, and were analyzed through whole-genome sequencing. The annual reporting of these data in Canada holds value.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium bovisTuberculosisGenetic VariationHumansCanadaPhylogenyAntitubercular AgentsWhole Genome SequencingGenome, BacterialDrug Resistance, BacterialMicrobial Sensitivity TestsAnimalsMutationGenotypeCattle

Stichwörter der Autor:innen

Mycobacterium bovisantimicrobial resistancebovine tuberculosisgenomic relatedness

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • National Reference Centre for Mycobacteriology, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada.
  • National Reference Laboratory for Bovine Tuberculosis, Ottawa Animal Health Laboratory, Canadian Food Inspection Agency, Ottawa, Ontario, Canada.
  • Division of Diagnostic and Applied Microbiology, Laboratory Medicine and Pathology, University of Alberta and Alberta Precision Laboratories, Edmonton, Alberta, Canada.
  • Laboratoire de santé publique du Québec, INSPQ, Québec City, Canada.
  • Public Health Laboratory, BC Centre for Disease Control, Vancouver, British Columbia, Canada.

ORCID-Profile: Meenu K Sharma, Olga Andrievskaia, Melissa Richard-Greenblatt, Elizabeth Simms, Md Rashedul Islam, Hafid Soualhine

Förderung

  • Canadian Food Inspection Agency

Zitieren

APA

Sharma, M. K., Andrievskaia, O., Tyrrell, G. J., Akochy, P. M., Sekirov, I., Richard-Greenblatt, M., Ma, A., Adam, H., Alawa, M., Simms, E., Islam, M. R., Rabb, M., & Soualhine, H. (2026). Genomic diversity of human-associated Mycobacterium bovis in Canada. Microbiology Spectrum, 14(11). https://doi.org/10.1128/spectrum.01485-26

Vancouver

Sharma MK, Andrievskaia O, Tyrrell GJ, Akochy PM, Sekirov I, Richard-Greenblatt M, et al. Genomic diversity of human-associated Mycobacterium bovis in Canada. Microbiology Spectrum. 2026;14(11). doi:10.1128/spectrum.01485-26

BibTeX
@article{Sharma2026,
  author = {Sharma, Meenu K and Andrievskaia, Olga and Tyrrell, Gregory J and Akochy, Pierre-Marie and Sekirov, Inna and Richard-Greenblatt, Melissa and Ma, Angela and Adam, Heather and Alawa, Mohey and Simms, Elizabeth and Islam, Md Rashedul and Rabb, Melissa and Soualhine, Hafid},
  title = {Genomic diversity of human-associated Mycobacterium bovis in Canada},
  journal = {Microbiology Spectrum},
  year = {2026},
  volume = {14},
  number = {11},
  doi = {10.1128/spectrum.01485-26}
}
Kostenlos starten →